Effect of long-term salmeterol treatment on exercise-induced asthma

The New England Journal of Medicine
J A NelsonE R McFadden

Abstract

With long-term administration of salmeterol, the extent of protection afforded by the drug against experimental precipitants of asthma such as methacholine and adenosine may decrease. Whether this effect extends to a clinically relevant stimulus such as exercise is unknown. We performed a random-order, double-blind, crossover trial in 20 patients with exercise-induced asthma. Each patient received inhaled salmeterol or placebo twice daily for a month, with a one-week washout period between treatments. The patients performed cycle ergometry while breathing frigid air 30 minutes after the morning dose and 9 hours later on the 1st, 14th, and 29th study days. The primary end point was the extent of the decrease in forced expiratory volume in 1 second (FEV1) 10 minutes after exertion. With placebo, significant airway narrowing developed at all times (mean [+/-SE] decrease from base line in FEV1, 19+/-2 percent in the morning and 18+/-2 percent in the evening). The morning dose of salmeterol attenuated the degree of bronchoconstriction at all times (decrease in FEV1 on day 1, 5+/-2 percent; on day 14, 10+/-3 percent; and on day 29, 9+/-3 percent; P=0.10). Its ability to act throughout the day, however, decreased with long-term admini...Continue Reading

Associated Clinical Trials

References

Apr 1, 1977·British Journal of Diseases of the Chest·M R HetzelT J Clark
Oct 6, 1977·The New England Journal of Medicine·R H StraussJ J Jaeger
Aug 1, 1992·Archives of Disease in Childhood·C P Green, J F Price
Oct 22, 1992·The New England Journal of Medicine·B J O'ConnorP J Barnes
Nov 12, 1992·The New England Journal of Medicine·D S PearlmanS W Yancey
Dec 8, 1990·Lancet·M R SearsG P Herbison
May 1, 1988·Journal of Applied Physiology·I A GilbertE R McFadden
Mar 1, 1995·The Journal of Allergy and Clinical Immunology·E R McFadden
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·J P KempA Van As
Oct 2, 1993·Lancet·D W CockcroftB C Rutherford
May 12, 1994·The New England Journal of Medicine·E R McFadden, I A Gilbert
Jan 1, 1996·American Journal of Respiratory and Critical Care Medicine·M D Inman, P M O'Byrne

❮ Previous
Next ❯

Citations

Dec 10, 2008·Current Allergy and Asthma Reports·Teal S Hallstrand, William R Henderson
Sep 24, 1999·The American Journal of Medicine·M KorosecE R McFadden
Nov 30, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Luis PrietoAnna Ferrer
Feb 11, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·John M WeilerPaul M Dorinsky
Aug 9, 2006·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·William E Berger
Sep 25, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Ricardo A Tan, Sheldon L Spector
Jun 29, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·C VidalA González-Quintela
Mar 27, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J T Li
Jul 25, 2003·Pulmonary Pharmacology & Therapeutics·Gaetano Caramori, Ian Adcock
Sep 19, 2002·British Journal of Clinical Pharmacology·Brian J Lipworth
Jul 17, 1998·The New England Journal of Medicine·J Hansen-Flaschen, H Schotland
Dec 29, 1998·The New England Journal of Medicine·I Aziz, B J Lipworth
Oct 30, 2001·The New England Journal of Medicine·E T Naureckas, J Solway
Mar 7, 2009·The New England Journal of Medicine·Christopher H Fanta
Jun 18, 2010·Journal of Medicinal Food·Emmanuel E IlodigweChukwuemeka S Nworu
May 17, 2000·Current Opinion in Pulmonary Medicine·C J Clark, L M Cochrane
May 17, 2000·Current Opinion in Pulmonary Medicine·J C KipsR A Pauwels
Mar 27, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Douglas C CowanD Robin Taylor
Oct 18, 2000·Journal of the American Academy of Nurse Practitioners·S L Stach
Oct 27, 2001·BMJ : British Medical Journal·C Cates
Nov 21, 2000·Postgraduate Medical Journal·O J Dempsey
Aug 19, 2000·Thorax·C ByrnesA Bush
Dec 3, 2005·American Journal of Respiratory and Critical Care Medicine·Michael E WechslerUNKNOWN National Heart, Lung, and Blood Institute's Asthma Clinical Research Network
May 3, 2013·American Journal of Respiratory and Critical Care Medicine·Jonathan P ParsonsUNKNOWN American Thoracic Society Subcommittee on Exercise-induced Bronchoconstriction
May 23, 2002·American Journal of Respiratory and Critical Care Medicine·Nicola A HananiaBurton F Dickey
Dec 17, 2009·Therapeutics and Clinical Risk Management·James P Kemp
May 21, 2008·Sports Medicine·Antti AlarantaIlkka Helenius
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·P Flood-Page, N C Barnes
Jan 22, 2005·Treatments in Respiratory Medicine·Sandra D Anderson
Nov 16, 2013·American Journal of Respiratory and Critical Care Medicine·Matteo BoniniElliot Israel
Dec 11, 1999·Proceedings of the Association of American Physicians·J M Drazen
Mar 30, 2010·Pharmaceuticals·Giovanni BarisioneVito Brusasco
Jul 9, 2013·Immunology and Allergy Clinics of North America·Johan LarssonBarbro Dahlén
Jul 9, 2013·Immunology and Allergy Clinics of North America·Vibeke BackerCeleste Porsbjerg
Jan 5, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·John M WeilerUNKNOWN Joint Council of Allergy, Asthma and Immunology
Feb 4, 2010·Endocrinology and Metabolism Clinics of North America·Bernd WolfarthWilfried Kindermann
Jun 28, 2008·The Journal of Allergy and Clinical Immunology·Miles Weinberger
Aug 8, 2007·Pharmacology & Therapeutics·Richard A BondClive P Page
Apr 20, 2006·International Journal of Clinical Practice·V TsagarakiS L Markantonis
Feb 26, 2008·Pharmacotherapy·Hengameh H RaissyH William Kelly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.